Last 12 months
Inside the activity.
0 purchase rows · 31 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 1 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 1 |
| Feb 2026 | 0 | 11 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 15 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 3 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 27, 2020 Filed Feb 28, 2020 19:31 UTC |
Keith R. AlexandraCEO - Beauty
|
SaleCommon Stock | 633 | $117.49 | $74,370.16 |
DisclosureSEC source: 0001127602-20-008305 · form4.xml · nonDerivative · entry 2 Keith R. Alexandra · CIK 0001710268 · CEO - Beauty 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 9,516.381 F1 · shares: Shares sold to cover tax obligation upon settlement of Restricted Stock Unit award. F2 · price: Weighted average price of the shares sold. The price range was $117.31 to $117.55. Full information regarding the number of shares sold at each separate price available upon request. F3 · balance_after: Total includes grant of dividend equivalents in the form of Restricted Stock Units (RSU's) settled in common stock. Read SEC document |
| February 27, 2020 Filed Feb 28, 2020 19:31 UTC |
Keith R. AlexandraCEO - Beauty
|
SaleCommon Stock | 2,343 | $117.49 | $275,275.32 |
DisclosureSEC source: 0001127602-20-008305 · form4.xml · nonDerivative · entry 1 Keith R. Alexandra · CIK 0001710268 · CEO - Beauty 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,162.032 F1 · shares: Shares sold to cover tax obligation upon settlement of Restricted Stock Unit award. F2 · price: Weighted average price of the shares sold. The price range was $117.31 to $117.55. Full information regarding the number of shares sold at each separate price available upon request. F3 · balance_after: Total includes grant of dividend equivalents in the form of Restricted Stock Units (RSU's) settled in common stock. Read SEC document |
| February 27, 2020 Filed Feb 28, 2020 19:33 UTC |
FergusonMchugh MaryLynnCEO - Family Care & P&G Ventur
|
SaleCommon Stock | 2,687 | $117.49 | $315,691.33 |
DisclosureSEC source: 0001127602-20-008307 · form4.xml · nonDerivative · entry 1 FergusonMchugh MaryLynn · CIK 0001613133 · CEO - Family Care & P&G Ventur 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 81,989.7592 F1 · shares: Shares sold to cover tax obligations upon settlement of Restricted Stock Unit award. F2 · price: Weighted average price of the shares sold. The price range was $117.31 to $117.55. Full information regarding the number of shares sold at each separate price available upon request. F3 · balance_after: Total includes grant of dividend equivalents in the form of Restricted Stock Units (RSU's) settled in common stock. Read SEC document |
| February 27, 2020 Filed Feb 28, 2020 19:35 UTC |
Moeller Jon RVice Chairman, COO and CFO
|
SaleCommon Stock | 688 | $117.49 | $80,832.02 |
DisclosureSEC source: 0001127602-20-008308 · form4.xml · nonDerivative · entry 2 Moeller Jon R · CIK 0001450613 · Vice Chairman, COO and CFO 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 7,086.52 F1 · shares: Shares sold to cover tax obligations upon settlement of Restricted Stock Unit award. F2 · price: Weighted average price of the shares sold. The price range was $117.31 to $117.55. Full information regarding the number of shares sold at each separate price available upon request. Read SEC document |
| February 27, 2020 Filed Feb 28, 2020 19:35 UTC |
Moeller Jon RVice Chairman, COO and CFO
|
SaleCommon Stock | 3,451 | $117.49 | $405,452.47 |
DisclosureSEC source: 0001127602-20-008308 · form4.xml · nonDerivative · entry 1 Moeller Jon R · CIK 0001450613 · Vice Chairman, COO and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 125,996.18 F1 · shares: Shares sold to cover tax obligations upon settlement of Restricted Stock Unit award. F2 · price: Weighted average price of the shares sold. The price range was $117.31 to $117.55. Full information regarding the number of shares sold at each separate price available upon request. Read SEC document |
| February 27, 2020 Filed Feb 28, 2020 19:37 UTC |
Majoras Deborah PChief Legal Officer & Secy
|
SaleCommon Stock | 2,738 | $117.49 | $321,683.24 |
DisclosureSEC source: 0001127602-20-008309 · form4.xml · nonDerivative · entry 1 Majoras Deborah P · CIK 0001483177 · Chief Legal Officer & Secy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,509.151 F1 · shares: Shares sold to cover tax obligations upon settlement of Restricted Stock Unit award. F2 · price: Weighted average price of the shares sold. The price range was $117.31 to $117.55. Full information regarding the number of shares sold at each separate price available upon request. F3 · balance_after: Total includes grant of dividend equivalents in the form of Restricted Stock Units (RSU's) settled in common stock. Read SEC document |
| February 21, 2020 Filed Feb 25, 2020 21:03 UTC |
Jejurikar ShaileshCEO - Fabric & Home Care
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 10,000 | $0.00 Strike: $63.05 | $0.00 |
DisclosureSEC source: 0001127602-20-007564 · form4.xml · derivative · entry 7 Jejurikar Shailesh · CIK 0001746310 · CEO - Fabric & Home Care 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,000 shares Expires 2021-02-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 21, 2020 Filed Feb 25, 2020 21:03 UTC |
Jejurikar ShaileshCEO - Fabric & Home Care
|
SaleCommon Stock | 10,000 | $127.41 | $1,274,105.00 |
DisclosureSEC source: 0001127602-20-007564 · form4.xml · nonDerivative · entry 2 Jejurikar Shailesh · CIK 0001746310 · CEO - Fabric & Home Care 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,370.087 F2 · price: Weighted average price of the shares sold. The price range was $126.00 to $127.98. Full information regarding the number of shares sold at each separate price available upon request. Read SEC document |
| February 21, 2020 Filed Feb 25, 2020 21:03 UTC |
Jejurikar ShaileshCEO - Fabric & Home Care
|
Exercise / conversionCommon Stock | 10,000 | $63.05 | $630,500.00 |
DisclosureSEC source: 0001127602-20-007564 · form4.xml · nonDerivative · entry 1 Jejurikar Shailesh · CIK 0001746310 · CEO - Fabric & Home Care 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,370.087 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Total includes grant of dividend equivalents in the form of Restricted Stock Units (RSU's) settled in common stock. Read SEC document |
| February 21, 2020 Filed Feb 25, 2020 21:06 UTC |
Fish Kathleen BChf Rsch, Dev & Innv Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 19,023 | $0.00 Strike: $67.52 | $0.00 |
DisclosureSEC source: 0001127602-20-007572 · form4.xml · derivative · entry 5 Fish Kathleen B · CIK 0001598156 · Chf Rsch, Dev & Innv Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,023 Underlying: Common Stock · 19,023 shares Expires 2022-02-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 21, 2020 Filed Feb 25, 2020 21:06 UTC |
Fish Kathleen BChf Rsch, Dev & Innv Officer
|
SaleCommon Stock | 19,023 | $126.00 | $2,396,901.80 |
DisclosureSEC source: 0001127602-20-007572 · form4.xml · nonDerivative · entry 2 Fish Kathleen B · CIK 0001598156 · Chf Rsch, Dev & Innv Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,198.829 F2 · price: Weighted average price of the shares sold. The price range was $126.00 to $126.03. Full information regarding the number of shares sold at each separate price available upon request. Read SEC document |
| February 21, 2020 Filed Feb 25, 2020 21:06 UTC |
Fish Kathleen BChf Rsch, Dev & Innv Officer
|
Exercise / conversionCommon Stock | 19,023 | $67.52 | $1,284,432.96 |
DisclosureSEC source: 0001127602-20-007572 · form4.xml · nonDerivative · entry 1 Fish Kathleen B · CIK 0001598156 · Chf Rsch, Dev & Innv Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,221.829 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Total includes grant of dividend equivalents in the form of Restricted Stock Units (RSU's) settled in common stock. Read SEC document |
| February 21, 2020 Filed Feb 25, 2020 21:09 UTC |
Moeller Jon RVice Chairman, COO and CFO
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 19,077 | $0.00 Strike: $76.18 | $0.00 |
DisclosureSEC source: 0001127602-20-007578 · form4.xml · derivative · entry 9 Moeller Jon R · CIK 0001450613 · Vice Chairman, COO and CFO 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 0 Underlying: Common Stock · 19,077 shares Expires 2023-02-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 21, 2020 Filed Feb 25, 2020 21:09 UTC |
Moeller Jon RVice Chairman, COO and CFO
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 127,987 | $0.00 Strike: $76.18 | $0.00 |
DisclosureSEC source: 0001127602-20-007578 · form4.xml · derivative · entry 8 Moeller Jon R · CIK 0001450613 · Vice Chairman, COO and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 127,987 shares Expires 2023-02-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 21, 2020 Filed Feb 25, 2020 21:09 UTC |
Moeller Jon RVice Chairman, COO and CFO
|
SaleCommon Stock | 19,077 | $127.32 | $2,428,841.67 |
DisclosureSEC source: 0001127602-20-007578 · form4.xml · nonDerivative · entry 4 Moeller Jon R · CIK 0001450613 · Vice Chairman, COO and CFO 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 7,774.52 F3 · price: Weighted average price of the shares sold. The price range was $127.28 to $127.43. Full information regarding the number of shares sold at each separate price available upon request. Read SEC document |
| February 21, 2020 Filed Feb 25, 2020 21:09 UTC |
Moeller Jon RVice Chairman, COO and CFO
|
Exercise / conversionCommon Stock | 19,077 | $76.18 | $1,453,285.86 |
DisclosureSEC source: 0001127602-20-007578 · form4.xml · nonDerivative · entry 3 Moeller Jon R · CIK 0001450613 · Vice Chairman, COO and CFO 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 26,851.52 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Total includes grant of dividend equivalents in the form of Restricted Stock Units (RSU's) settled in common stock. Read SEC document |
| February 21, 2020 Filed Feb 25, 2020 21:09 UTC |
Moeller Jon RVice Chairman, COO and CFO
|
SaleCommon Stock | 127,987 | $127.31 | $16,293,948.18 |
DisclosureSEC source: 0001127602-20-007578 · form4.xml · nonDerivative · entry 2 Moeller Jon R · CIK 0001450613 · Vice Chairman, COO and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 129,447.18 F2 · price: Weighted average price of the shares sold. The price range was $127.06 to $127.78. Full information regarding the number of shares sold at each separate price available upon request. Read SEC document |
| February 21, 2020 Filed Feb 25, 2020 21:09 UTC |
Moeller Jon RVice Chairman, COO and CFO
|
Exercise / conversionCommon Stock | 127,987 | $76.18 | $9,750,049.66 |
DisclosureSEC source: 0001127602-20-007578 · form4.xml · nonDerivative · entry 1 Moeller Jon R · CIK 0001450613 · Vice Chairman, COO and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 257,434.18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Total includes grant of dividend equivalents in the form of Restricted Stock Units (RSU's) settled in common stock. Read SEC document |
| February 21, 2020 Filed Feb 25, 2020 21:13 UTC |
Taylor David SDirector · Chairman, President & CEO
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 74,520 | $0.00 Strike: $79.05 | $0.00 |
DisclosureSEC source: 0001127602-20-007581 · form4.xml · derivative · entry 4 Taylor David S · CIK 0001505989 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 74,520 shares Expires 2023-09-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 21, 2020 Filed Feb 25, 2020 21:13 UTC |
Taylor David SDirector · Chairman, President & CEO
|
SaleCommon Stock | 74,520 | $127.30 | $9,486,500.33 |
DisclosureSEC source: 0001127602-20-007581 · form4.xml · nonDerivative · entry 2 Taylor David S · CIK 0001505989 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 226,404.6064 F2 · price: Weighted average price of the shares sold. The price range was $127.07 to $127.58. Full information regarding the number of shares sold at each separate price available upon request. Read SEC document |
| February 21, 2020 Filed Feb 25, 2020 21:13 UTC |
Taylor David SDirector · Chairman, President & CEO
|
Exercise / conversionCommon Stock | 74,520 | $79.05 | $5,890,806.00 |
DisclosureSEC source: 0001127602-20-007581 · form4.xml · nonDerivative · entry 1 Taylor David S · CIK 0001505989 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 300,924.6064 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Total includes grant of dividend equivalents in the form of Restricted Stock Units (RSU's) settled in common stock. Read SEC document |
| February 21, 2020 Filed Feb 25, 2020 21:15 UTC |
Francisco Ma. FatimaCEO - Baby & Feminine Care
|
SaleCommon Stock | 1,500 | $128.00 | $192,000.00 |
DisclosureSEC source: 0001127602-20-007583 · form4.xml · nonDerivative · entry 2 Francisco Ma. Fatima · CIK 0001747222 · CEO - Baby & Feminine Care 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 861.166 Read SEC document |
| February 21, 2020 Filed Feb 25, 2020 21:15 UTC |
Francisco Ma. FatimaCEO - Baby & Feminine Care
|
SaleCommon Stock | 1,500 | $127.50 | $191,250.00 |
DisclosureSEC source: 0001127602-20-007583 · form4.xml · nonDerivative · entry 1 Francisco Ma. Fatima · CIK 0001747222 · CEO - Baby & Feminine Care 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,361.166 F1 · balance_after: Total includes grant of dividend equivalents in the form of Restricted Stock Units (RSU's) settled in common stock. Read SEC document |
| February 21, 2020 Filed Feb 25, 2020 23:16 UTC |
PELTZ NELSONDirector
TRIAN FUND MANAGEMENT, L.P.Director
|
OtherCommon Stock | 1,006,112 | $126.70 | $127,474,390.40 |
DisclosureSEC source: 0001209191-20-012693 · doc4.xml · nonDerivative · entry 1 PELTZ NELSON · CIK 0000928265 · Director TRIAN FUND MANAGEMENT, L.P. · CIK 0001345471 · Director Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · Please see explanation below Disclosed balance after: 31,144,647 F1 · kind: Represents a distribution of shares to a limited partner of the parent of a Trian Entity (defined below) in connection with the expiration of a lock-up period. F2 · ownership.nature: Trian Fund Management, L.P. ("Trian Management") serves as the management company for Trian Partners, L.P., Trian Partners Master Fund, L.P., Trian Partners Parallel Fund I, L.P., Trian Partners Strategic Investment Fund-A, L.P., Trian Partners Strategic Co-Investment Fund-A, L.P., Trian Partners Strategic Investment Fund-N, L.P., Trian Partners Strategic Investment Fund-D, L.P., Trian Partners Fund (Sub)-G, L.P., Trian Partners Strategic Fund-G II, L.P., Trian Partners Strategic Fund G-III, L.P., Trian Partners Strategic Fund-K, L.P., Trian Partners Strategic Fund-C, Ltd., Trian Partners Co-Investment Opportunities Fund, Ltd. and Trian SPV (Sub) XII, L.P (collectively, the "Trian Entities") and as such determines the investment and voting decisions of the Trian Entities with respect to the shares of the Issuer held by them. F3 · ownership.nature: (FN 2, contd.) Mr. Peltz is a member of Trian Fund Management GP, LLC, which is the general partner of Trian Management, and therefore is in a position to determine the investment and voting decisions made by Trian Management on behalf of the Trian Entities. Accordingly, Mr. Peltz and Trian Management may be deemed to indirectly beneficially own (as that term is defined in Rule 13d-3 under the Securities Exchange Act of 1934) the shares beneficially owned by the Trian Entities. The Reporting Persons disclaim beneficial ownership of such shares except to the extent of their respective pecuniary interests therein and this report shall not be deemed an admission that the Reporting Persons are the beneficial owner of such securities for purposes of Section 16 or for any other purpose. Mr. Peltz is a director of the Issuer. Read SEC document |
| February 18, 2020 Filed Feb 25, 2020 21:03 UTC |
Jejurikar ShaileshCEO - Fabric & Home Care
|
GrantRestricted Stock Units · Derivative | 11.918 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-007564 · form4.xml · derivative · entry 6 Jejurikar Shailesh · CIK 0001746310 · CEO - Fabric & Home Care 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 78.629 Underlying: Common Stock · 11.918 shares Expires not disclosed F4 · derivative.exercise_price: Dividend equivalents in the form of Restricted Stock Units (RSUs) previously awarded pursuant to issuer's retirement program. All such RSUs represent a contingent right to receive Procter & Gamble common stock. F5 · derivative.exercise_date: These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account. F5 · derivative.expiration_date: These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account. Read SEC document |
| February 18, 2020 Filed Feb 25, 2020 21:06 UTC |
Fish Kathleen BChf Rsch, Dev & Innv Officer
|
GrantRestricted Stock Units · Derivative | 30.853 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-007572 · form4.xml · derivative · entry 4 Fish Kathleen B · CIK 0001598156 · Chf Rsch, Dev & Innv Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 433.037 Underlying: Common Stock · 30.853 shares Expires not disclosed F4 · derivative.exercise_price: Dividend equivalents in the form of Restricted Stock Units (RSUs) previously awarded pursuant to issuer's retirement program. All such RSUs represent a contingent right to receive Procter & Gamble common stock. F5 · derivative.exercise_date: These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account. F5 · derivative.expiration_date: These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account. Read SEC document |
| February 18, 2020 Filed Feb 25, 2020 21:09 UTC |
Moeller Jon RVice Chairman, COO and CFO
|
GrantRestricted Stock Units · Derivative | 115.757 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-007578 · form4.xml · derivative · entry 7 Moeller Jon R · CIK 0001450613 · Vice Chairman, COO and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,152.947 Underlying: Common Stock · 115.757 shares Expires not disclosed F5 · derivative.exercise_price: Dividend equivalents in the form of Restricted Stock Units (RSUs) previously awarded pursuant to issuer's retirement program. All such RSUs represent a contingent right to receive Procter & Gamble common stock. F6 · derivative.exercise_date: These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account. F6 · derivative.expiration_date: These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account. Read SEC document |
| February 18, 2020 Filed Feb 25, 2020 21:15 UTC |
Francisco Ma. FatimaCEO - Baby & Feminine Care
|
GrantRestricted Stock Units · Derivative | 14.818 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-007583 · form4.xml · derivative · entry 5 Francisco Ma. Fatima · CIK 0001747222 · CEO - Baby & Feminine Care 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 91.239 Underlying: Common Stock · 14.818 shares Expires not disclosed F2 · derivative.exercise_price: Dividend equivalents in the form of Restricted Stock Units (RSUs) previously awarded pursuant to issuer's retirement program. All such RSUs represent a contingent right to receive Procter & Gamble common stock. F3 · derivative.exercise_date: These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account. F3 · derivative.expiration_date: These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account. Read SEC document |
| February 18, 2020 Filed Feb 28, 2020 19:30 UTC |
TASTAD CAROLYN MGroup Pres-Chief Sales Officer
|
GrantRestricted Stock Units · Derivative | 30.054 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-008304 · form4.xml · derivative · entry 6 TASTAD CAROLYN M · CIK 0001597938 · Group Pres-Chief Sales Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 406.862 Underlying: Common Stock · 30.054 shares Expires not disclosed F4 · derivative.exercise_price: Dividend equivalents in the form of Restricted Stock Units (RSUs) previously awarded pursuant to issuer's retirement program. All such RSUs represent a contingent right to receive Procter & Gamble common stock. F5 · derivative.exercise_date: These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account. F5 · derivative.expiration_date: These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account. Read SEC document |
| February 18, 2020 Filed Feb 28, 2020 19:31 UTC |
Keith R. AlexandraCEO - Beauty
|
GrantRestricted Stock Units · Derivative | 21.251 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-008305 · form4.xml · derivative · entry 7 Keith R. Alexandra · CIK 0001710268 · CEO - Beauty 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 199.751 Underlying: Common Stock · 21.251 shares Expires not disclosed F5 · derivative.exercise_price: Dividend equivalents in the form of Restricted Stock Units (RSUs) previously awarded pursuant to issuer's retirement program. All such RSUs represent a contingent right to receive Procter & Gamble common stock. F6 · derivative.exercise_date: These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account. F6 · derivative.expiration_date: These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account. Read SEC document |
| February 18, 2020 Filed Feb 28, 2020 19:33 UTC |
FergusonMchugh MaryLynnCEO - Family Care & P&G Ventur
|
GrantRestricted Stock Units · Derivative | 100.477 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-008307 · form4.xml · derivative · entry 7 FergusonMchugh MaryLynn · CIK 0001613133 · CEO - Family Care & P&G Ventur 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,662.02 Underlying: Common Stock · 100.477 shares Expires not disclosed F5 · derivative.exercise_price: Dividend equivalents in the form of Restricted Stock Units (RSUs) previously awarded pursuant to issuer's retirement program. All such RSUs represent a contingent right to receive Procter & Gamble common stock. F6 · derivative.exercise_date: These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account. F6 · derivative.expiration_date: These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account. Read SEC document |
| February 18, 2020 Filed Feb 28, 2020 19:37 UTC |
Majoras Deborah PChief Legal Officer & Secy
|
GrantRestricted Stock Units · Derivative | 65.065 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-008309 · form4.xml · derivative · entry 4 Majoras Deborah P · CIK 0001483177 · Chief Legal Officer & Secy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,512.695 Underlying: Common Stock · 65.065 shares Expires not disclosed F5 · derivative.exercise_price: Dividend equivalents in the form of Restricted Stock Units (RSUs) previously awarded pursuant to issuer's retirement program. All such RSUs represent a contingent right to receive Procter & Gamble common stock. F6 · derivative.exercise_date: These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account. F6 · derivative.expiration_date: These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account. Read SEC document |
| February 18, 2020 Filed Mar 3, 2020 14:26 UTC |
Bishop Steven DCEO - Health Care
|
GrantRestricted Stock Units · Derivative | 96.242 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-008739 · form4.xml · derivative · entry 4 Bishop Steven D · CIK 0001669212 · CEO - Health Care 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,576.497 Underlying: Common Stock · 96.242 shares Expires not disclosed F5 · derivative.exercise_price: Dividend equivalents in the form of Retirement Restricted Stock Units (RSUs) previously awarded pursuant to Issuer's retirement program. All such RSUs represent a contingent right to receive Procter & Gamble common stock. F6 · derivative.exercise_date: These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account. F6 · derivative.expiration_date: These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account. Read SEC document |
| February 18, 2020 Filed Mar 3, 2020 14:29 UTC |
Grabowski Mary TheresaChief Human Resources Officer
|
GrantRestricted Stock Units · Derivative | 2.866 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-008741 · form4.xml · derivative · entry 4 Grabowski Mary Theresa · CIK 0001747030 · Chief Human Resources Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6.079 Underlying: Common Stock · 2.866 shares Expires not disclosed F3 · derivative.exercise_price: Dividend equivalents in the form of Restricted Stock Units (RSUs) previously awarded pursuant to issuer's retirement program. All such RSUs represent a contingent right to receive Procter & Gamble common stock. F4 · derivative.exercise_date: These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account. F4 · derivative.expiration_date: These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account. Read SEC document |
| February 18, 2020 Filed Mar 3, 2020 14:34 UTC |
Pritchard Marc S.Chief Brand Officer
|
GrantRestricted Stock Units · Derivative | 150.748 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-008744 · form4.xml · derivative · entry 7 Pritchard Marc S. · CIK 0001440364 · Chief Brand Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,675.184 Underlying: Common Stock · 150.748 shares Expires not disclosed F3 · derivative.exercise_price: Dividend equivalents in the form of Restricted Stock Units (RSUs) previously awarded pursuant to issuer's retirement program. All such RSUs represent a contingent right to receive Procter & Gamble common stock. F4 · derivative.exercise_date: These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account. F4 · derivative.expiration_date: These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account. Read SEC document |
| February 18, 2020 Filed Mar 3, 2020 14:30 UTC |
Coombe Gary ACEO - Grooming
|
GrantRestricted Stock Units · Derivative | 21.381 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-008742 · form4.xml · derivative · entry 4 Coombe Gary A · CIK 0001623622 · CEO - Grooming 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 275.819 Underlying: Common Stock · 21.381 shares Expires not disclosed F3 · derivative.exercise_price: Dividend equivalents in the form of Restricted Stock Units (RSUs) previously awarded pursuant to issuer's retirement program. All such RSUs represent a contingent right to receive Procter & Gamble common stock. F4 · derivative.exercise_date: These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account. F4 · derivative.expiration_date: These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account. Read SEC document |
| January 28, 2020 Filed Jan 29, 2020 14:24 UTC |
TASTAD CAROLYN MGroup Pres-Chief Sales Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 29,240 | $0.00 Strike: $78.66 | $0.00 |
DisclosureSEC source: 0001127602-20-002592 · form4.xml · derivative · entry 10 TASTAD CAROLYN M · CIK 0001597938 · Group Pres-Chief Sales Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 29,240 shares Expires 2024-02-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 28, 2020 Filed Jan 29, 2020 14:24 UTC |
TASTAD CAROLYN MGroup Pres-Chief Sales Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 8,145 | $0.00 Strike: $79.05 | $0.00 |
DisclosureSEC source: 0001127602-20-002592 · form4.xml · derivative · entry 9 TASTAD CAROLYN M · CIK 0001597938 · Group Pres-Chief Sales Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 8,145 shares Expires 2023-09-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 28, 2020 Filed Jan 29, 2020 14:24 UTC |
TASTAD CAROLYN MGroup Pres-Chief Sales Officer
|
SaleCommon Stock | 29,240 | $126.28 | $3,692,374.57 |
DisclosureSEC source: 0001127602-20-002592 · form4.xml · nonDerivative · entry 5 TASTAD CAROLYN M · CIK 0001597938 · Group Pres-Chief Sales Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,190.971 F1 · price: Weighted average price of the shares sold. The price range was $126.25 to $126.37. Full information regarding the number of shares sold at each separate price available upon request. Read SEC document |
| January 28, 2020 Filed Jan 29, 2020 14:24 UTC |
TASTAD CAROLYN MGroup Pres-Chief Sales Officer
|
Exercise / conversionCommon Stock | 29,240 | $78.66 | $2,300,018.40 |
DisclosureSEC source: 0001127602-20-002592 · form4.xml · nonDerivative · entry 4 TASTAD CAROLYN M · CIK 0001597938 · Group Pres-Chief Sales Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 89,430.971 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 28, 2020 Filed Jan 29, 2020 14:24 UTC |
TASTAD CAROLYN MGroup Pres-Chief Sales Officer
|
SaleCommon Stock | 8,145 | $126.28 | $1,028,535.94 |
DisclosureSEC source: 0001127602-20-002592 · form4.xml · nonDerivative · entry 3 TASTAD CAROLYN M · CIK 0001597938 · Group Pres-Chief Sales Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,190.971 F1 · price: Weighted average price of the shares sold. The price range was $126.25 to $126.37. Full information regarding the number of shares sold at each separate price available upon request. Read SEC document |
| January 28, 2020 Filed Jan 29, 2020 14:24 UTC |
TASTAD CAROLYN MGroup Pres-Chief Sales Officer
|
Exercise / conversionCommon Stock | 8,145 | $79.05 | $643,862.25 |
DisclosureSEC source: 0001127602-20-002592 · form4.xml · nonDerivative · entry 2 TASTAD CAROLYN M · CIK 0001597938 · Group Pres-Chief Sales Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,335.971 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 27, 2020 Filed Jan 28, 2020 14:45 UTC |
Taylor David SDirector · Chairman, President & CEO
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 58,297 | $0.00 Strike: $76.18 | $0.00 |
DisclosureSEC source: 0001127602-20-002477 · form4.xml · derivative · entry 4 Taylor David S · CIK 0001505989 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 58,297 shares Expires 2023-02-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 27, 2020 Filed Jan 28, 2020 14:45 UTC |
Taylor David SDirector · Chairman, President & CEO
|
SaleCommon Stock | 58,297 | $125.93 | $7,341,282.91 |
DisclosureSEC source: 0001127602-20-002477 · form4.xml · nonDerivative · entry 2 Taylor David S · CIK 0001505989 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 225,772.1714 F1 · price: Weighted average price of the shares sold. The price range was $125.69 to $125.99. Full information regarding the number of shares sold at each separate price available upon request. Read SEC document |
| January 27, 2020 Filed Jan 28, 2020 14:45 UTC |
Taylor David SDirector · Chairman, President & CEO
|
Exercise / conversionCommon Stock | 58,297 | $76.18 | $4,441,065.46 |
DisclosureSEC source: 0001127602-20-002477 · form4.xml · nonDerivative · entry 1 Taylor David S · CIK 0001505989 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 284,069.1714 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 24, 2020 Filed Jan 27, 2020 18:46 UTC |
Francisco Ma. FatimaCEO - Baby & Feminine Care
|
SaleCommon Stock | 3,000 | $126.50 | $379,500.00 |
DisclosureSEC source: 0001127602-20-002393 · form4.xml · nonDerivative · entry 1 Francisco Ma. Fatima · CIK 0001747222 · CEO - Baby & Feminine Care 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,856.081 Read SEC document |
| December 19, 2019 Filed Mar 3, 2020 14:30 UTC |
Coombe Gary ACEO - Grooming
|
GiftCommon Stock | 323 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-008742 · form4.xml · nonDerivative · entry 1 Coombe Gary A · CIK 0001623622 · CEO - Grooming 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,194 Read SEC document |
| December 10, 2019 Filed Dec 12, 2019 15:13 UTC |
MCNERNEY W JAMES JRDirector
|
GrantCommon Stock | 322 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-034856 · form4.xml · nonDerivative · entry 1 MCNERNEY W JAMES JR · CIK 0001182055 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 80,460.23 F1 · price: Common Stock awarded pursuant to The Procter & Gamble 2019 Stock and Incentive Compensation Plan. F2 · balance_after: Total includes grant of dividend equivalents in the form of Restricted Stock Units. Read SEC document |
| December 10, 2019 Filed Dec 12, 2019 15:14 UTC |
LUNDGREN TERRY JDirector
|
GrantCommon Stock | 292 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-034857 · form4.xml · nonDerivative · entry 1 LUNDGREN TERRY J · CIK 0001184471 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,762.661 F1 · price: Restricted Stock Units awarded pursuant to The Procter & Gamble 2019 Stock and Incentive Compensation Plan. F2 · balance_after: Total includes grant of dividend equivalents in the form of Restricted Stock Units (RSU's) and shares acquired through the issuer's dividend reinvestment plan. Read SEC document |
| December 10, 2019 Filed Dec 12, 2019 15:19 UTC |
COOK SCOTT DDirector
|
GrantCommon Stock | 136 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-034859 · form4.xml · nonDerivative · entry 1 COOK SCOTT D · CIK 0000938861 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 83,075.896 F1 · price: Common Stock awarded pursuant to The Procter & Gamble 2019 Stock and Incentive Compensation Plan F2 · balance_after: Total includes grant of dividend equivalents in the form of Restricted Stock Units. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.